Annual Assembly 2017

Annual Assembly

Regenerative Medicine: Current Concepts and Brave New Paradigms in the Treatment of Musculoskeletal Conditions

7 am-7:30 am                          

Registration Open

7:30 am-8:15 am
Rationale for Regenerative Interventions in Orthopedics and Sports Medicine

William Micheo, MD

  • Review the issues associated with common medications prescribed for orthopedic conditions such as tendinopathies and osteoarthritis.
  • Review the negative effects of common use injectates such as Marcaine and lidocaine.
  • Review the current evidence against the use of corticosteroids for tendon problems, arthritis, and in lumbar epidural injections.
8:15 am-9 am Where Does Prolotherapy Fit in the Treatment of Orthopedic Conditions?

Joanne Borg-Stein, MD

  • Basic overview of Prolotherapy including proposed mechanisms (compare and contrast).
  • What is the scientific literature to support these treatments?
  • How to apply Prolotherapy treatments in practice? 
9:15 am-9:30 am Break

9:30 am-10:15 am                                  Basic Terminology in Understanding Stem Cell Therapies: The ABCs of Stem Cell Language

Prathap Jayaram, MD 

  • What are Mesenchymal stem cells (MSCs)?
  • What are the actions/functions of MSCs?
  • What are the differences between bone marrow and adipose-derived stem cells?
  • Understand the terminologies used in scientific literature regarding stem cells/MSC.
10:15 am-11 am Evidence For/Against Platelet-rich Plasma (PRP) in Orthopedic Conditions

Kenneth Mautner, MD

  • What is the evidence for/against PRP for tendinopathies?
  • What is the evidence for/against PRP for cartilage pathology/OA?
  • Where the proper place for PRP in tendinopathies and cartilage pathology?
11 am-11:30 am Panel Discussion/Q&A

11:30 am-12:30 pm                                                         Lunch on Own

12:30 pm-1 pm Evidence For/Against Bone Marrow Stem Cell Therapies in Orthopedic Conditions

Mary A. Ambach, MD

  • What is the evidence for/against adipose-derived stem cell therapies in orthopedic conditions?
  • What are the concerns in using adipose-derived stem cell therapies in orthopedic conditions?
  • Are adipose-derived stem cells superior or inferior to bone-marrow derived stem cells?
  • How can a clinician be compliant using adipose-derived stem cell therapies
1 pm-1:30 pm  Orthobiologic Treatments for Spine Pain

John Pitts, MD

  • What are the various proposed biologic agents for spine conditions?
  • What is the evidence for/against PRP for disc; facet; facet and SI joint pathology?
  • What is the evidence for/against stem cell Txs for disc; facet; facet and SI joint pathology?
1:30 pm-2 pm  Technical Issues in the Harvesting and Concentrating Stem Cells (Bone Marrow and Adipose Derived)

Jay Bowen, DO

  • What equipment/staff need to be available?
  • Description of the collection techniques, including anesthesia, sterile field, positioning, potential danger zones, etc.
  • Recommendations for pain/anxiety control
  • Overview of guidance techniques
  • Tips and tricks for obtaining enough aspirate
  • Risks in harvesting and concentrating stem cells 
2 pm-2:30 pm Regulatory Issues in Regenerative Orthopedics

Imran Siddiqui, MD

  • Understand the FDA position on the use of stem cells/PRP
  • If we are using an FDA approved kit, are we OK?
  • Are there variations from state to state?
  • Are there liability concerns from the use of a non-standard treatment?
Is there data to support the safety and clinical efficacy of stem cells for orthopedic conditions?

2:30 pm-3 pm Expert Opinion on the Applications of Various Regenerative Treatments for Orthopedic Conditions              

All faculty

  • Dextrose
  • Has
  • PRP
  • Bone marrow MSCs
  • Adipose-derived MSCs
3 pm Summary/Conclusions

Gerard Malanga, MD